Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.

[1]  S. Dauwe,et al.  Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study. , 1987, The American journal of pathology.

[2]  R. Bast,et al.  Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. , 1986, Cancer research.

[3]  J. Niloff,et al.  The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer , 1986, American journal of obstetrics and gynecology.

[4]  S. Kilpatrick,et al.  Role of Ca 125 as tumor marker in ovarian carcinoma , 1986, Obstetrics and gynecology.

[5]  M. Leppilampi,et al.  Tumor‐associated antigen Ca 125 before and during the treatment of ovarian carcinoma , 1986, Obstetrics and gynecology.

[6]  U. Stenman,et al.  Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy , 1986, Cancer.

[7]  R. Bast,et al.  Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen. , 1984, American journal of obstetrics and gynecology.

[8]  T. Klug,et al.  Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bank , 1984, International journal of cancer.

[9]  J. V. Nagell,et al.  Tumour markers in ovarian cancer. , 1983 .

[10]  T. Cr,et al.  New developments in immunoperoxidase techniques and their application. , 1983, Archives of pathology & laboratory medicine.

[11]  R. Bast,et al.  Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.

[12]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  M. Herlyn,et al.  Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.

[14]  H. Fox,et al.  An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary. , 1979, Journal of clinical pathology.

[15]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[16]  L. Sternberger,et al.  THE UNLABELED ANTIBODY ENZYME METHOD OF IMMUNOHISTOCHEMISTRY PREPARATION AND PROPERTIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEX (HORSERADISH PEROXIDASE-ANTIHORSERADISH PEROXIDASE) AND ITS USE IN IDENTIFICATION OF SPIROCHETES , 1970, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  P. Gold,et al.  SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1965, The Journal of experimental medicine.

[18]  R. Kurman,et al.  Contributions of Immunocytochemistry to the Diagnosis and Study of Ovarian Neoplasms , 1984, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[19]  J. Douillard,et al.  Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA. , 1984, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[20]  R. Bast,et al.  Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. , 1983, American journal of clinical pathology.

[21]  V. Zurawski,et al.  Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies. , 1982 .

[22]  R. Scully.  Tumors of the ovary and maldeveloped gonads , 1979 .